Kirby M, Artibani W, Cardozo L, Chapple C, Diaz D C, De Ridder D, Espuna-Pons M, Haab F, Kelleher C, Milsom I, Van Kerrebroeck P, Vierhout M, Wagg A
Department of HertNet, The Hertfordshire Primary Care Research Network, and CRIPACC, Faculty of Health and Human Sciences, University of Hertfordshire, Hertfordshire, UK.
Int J Clin Pract. 2006 Oct;60(10):1263-71. doi: 10.1111/j.1742-1241.2006.01127.x.
Overactive bladder (OAB) affects an estimated 49 million people in Europe, but only a minority receive appropriate treatment. Others are bothered by unacceptable levels of symptoms that severely impair their quality of life and represent a significant financial burden to themselves and to their healthcare providers. Recently updated guidelines from the International Consultation on Incontinence (ICI) and the European Association of Urology (EAU) take account of important new developments in the management of bladder problems in both primary and secondary care. However, local implementation of previous guidance has been variable, with many patients with OAB and other bladder problems failing to gain full benefit from current clinical and scientific understanding of these conditions. The recent expansion of the range of treatments available for OAB and stress urinary incontinence makes it especially important that physicians become aware of the differential diagnosis of these conditions - the questions they need to ask, and the investigations which will help determine the most appropriate course of action.
据估计，欧洲有4900万人患有膀胱过度活动症（OAB），但只有少数人得到了适当的治疗。其他人则受到难以接受的症状困扰，这些症状严重损害了他们的生活质量，给他们自己和医疗服务提供者带来了巨大的经济负担。国际尿失禁咨询委员会（ICI）和欧洲泌尿外科学会（EAU）最近更新的指南考虑到了初级和二级护理中膀胱问题管理方面的重要新进展。然而，先前指南在各地的实施情况参差不齐，许多患有膀胱过度活动症和其他膀胱问题的患者未能从目前对这些病症的临床和科学认识中充分受益。最近，膀胱过度活动症和压力性尿失禁的治疗方法范围有所扩大，这使得医生了解这些病症的鉴别诊断尤为重要——他们需要询问的问题，以及有助于确定最合适治疗方案的检查。
